As the United States approximates 300,000 deaths from Coronavirus, the first vaccine sanctioned in the country to tackle the virus is arriving at health care facilities all over the U.S.
Vaccinations were expected to begin Monday in all 50 states. Nursing home residents and health care workers are first preferred to receive the vaccine made by Pfizer and its German partner BioNTech.
Despite the confident review on the vaccine front, the U.S. is still fighting record-breaking daily cases, and overcrowded hospitals as the nation approach another tragic milestone, 300,000 deaths, more than any country.
The United States has reported 16.2 million cases and 299,195 deaths, according to a survey conducted by Johns Hopkins University.
Albert Bourla (Pfizer CEO): 100 million vaccine shots will be distributed by the end of March 2021.
Albert Bourla, Pfizer CEO said on Monday that, like many people, he was planning to get his company’s unprecedented vaccine. “People will trust much more in the vaccine if the company’s CEO is getting it himself,” he said Monday on CNN while talking to Sanjay Gupta.
Before the end of the year, the company will have produced 50 million doses, half of which will go to U.S. states with the extra doses given out globally. By the end of March 2021, 100 million doses will have been circulated across the country, he said. The authorities have already asked for an extra 100 million doses, he said.
“By the end of this year, we will have approx 50 million doses available. Majority of them have already been manufactured. The following year, we will produce around 1.3 billion doses,” Albert said, but noted that not all the vaccinations as mentioned earlier were destined to the U.S. “We are working very persistently to expand this number as we realize the demand is very high.”